Novo Nordisk A/S (NONOF)
37.14
+0.39
(+1.06%)
USD |
OTCM |
Mar 19, 14:22
Novo Nordisk Market Cap : 164.94B for March 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 822.93B |
| Hims & Hers Health, Inc. | 5.502B |
| Genmab A/S | 15.90B |
| Ascendis Pharma A/S | 13.63B |
Market Cap Related Metrics
| PE Ratio | 10.71 |
| PS Ratio | 3.537 |
| PEG Ratio | 1.896 |
| Price to Book Value | 5.406 |
| Price to Free Cash Flow | 36.61 |
| Price | 37.14 |
| Earnings Yield | 9.34% |
| PEGY Ratio | 1.034 |
| Operating PE Ratio | 8.590 |
| Normalized PE Ratio | 10.71 |